Kalousková, B.; Skořepa, O.; Cmunt, D.; Abreu, C.; Krejčová, K.; Bláha, J.; Sieglová, I.; Král, V.; Fábry, M.; Pola, R.;
et al. Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells. Biomedicines 2021, 9, 1597.
https://doi.org/10.3390/biomedicines9111597
AMA Style
Kalousková B, Skořepa O, Cmunt D, Abreu C, Krejčová K, Bláha J, Sieglová I, Král V, Fábry M, Pola R,
et al. Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells. Biomedicines. 2021; 9(11):1597.
https://doi.org/10.3390/biomedicines9111597
Chicago/Turabian Style
Kalousková, Barbora, Ondřej Skořepa, Denis Cmunt, Celeste Abreu, Kateřina Krejčová, Jan Bláha, Irena Sieglová, Vlastimil Král, Milan Fábry, Robert Pola,
and et al. 2021. "Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells" Biomedicines 9, no. 11: 1597.
https://doi.org/10.3390/biomedicines9111597
APA Style
Kalousková, B., Skořepa, O., Cmunt, D., Abreu, C., Krejčová, K., Bláha, J., Sieglová, I., Král, V., Fábry, M., Pola, R., Pechar, M., & Vaněk, O.
(2021). Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells. Biomedicines, 9(11), 1597.
https://doi.org/10.3390/biomedicines9111597